Si-Bone (SIBN) Change in Acquisitions & Divestments (2019 - 2026)
Si-Bone's (SIBN) quarterly Change in Acquisitions & Divestments came in at $46.1 million in Q1 2026, down 23.12% year-on-year from $60.0 million in Q1 2025, and down 5.86% quarter-over-quarter from $49.0 million in Q4 2025.
Si-Bone (SIBN) Change in Acquisitions & Divestments (2019 - 2026) Analysis & Trends
Si-Bone's Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $46.1 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 23.12% year-over-year to $46.1 million in Q1 2026; TTM through Mar 2026 was $191.2 million, a 13.67% decrease from a year earlier, with the FY2025 full-year figure at $205.1 million, down 10.24% from the prior year.
- Change in Acquisitions & Divestments retreated to $46.1 million in Q1 2026 per SIBN's latest filing, from $49.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $67.5 million in Q3 2024 and bottomed at $23.0 million in Q2 2022.
- The 5-year median for Change in Acquisitions & Divestments is $44.0 million (2023), against an average of $43.7 million.
- Across the five-year window, Change in Acquisitions & Divestments tumbled 41.94% in 2023 and surged 175.51% in 2024, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $36.0 million in 2022, then grew by 22.22% to $44.0 million in 2023, then slipped by 4.55% to $42.0 million in 2024, then gained by 16.67% to $49.0 million in 2025, then declined by 5.86% to $46.1 million in 2026.
- Per Business Quant, the three latest SIBN Change in Acquisitions & Divestments figures stand at $46.1 million (Q1 2026), $49.0 million (Q4 2025), and $52.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Si-Bone | 753.03 Mn | 608.35 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.13 Mn |
| Mar 31, 2026 | 46.13 Mn |
| Dec 31, 2025 | 49.00 Mn |
| Dec 31, 2025 | 49.00 Mn |
| Sep 30, 2025 | 52.00 Mn |
| Sep 30, 2025 | 52.00 Mn |
| Jun 30, 2025 | 44.10 Mn |
| Jun 30, 2025 | 44.10 Mn |
| Mar 31, 2025 | 60.00 Mn |
| Mar 31, 2025 | 60.00 Mn |
| Dec 31, 2024 | 42.00 Mn |
| Dec 31, 2024 | 42.00 Mn |
| Sep 30, 2024 | 67.50 Mn |
| Sep 30, 2024 | 67.50 Mn |
| Jun 30, 2024 | 52.00 Mn |
| Jun 30, 2024 | 52.00 Mn |
| Mar 31, 2024 | 67.00 Mn |
| Mar 31, 2024 | 67.00 Mn |
| Dec 31, 2023 | 44.00 Mn |
| Dec 31, 2023 | 44.00 Mn |